As the Senior Director of Customer Engagement at Remarque Systems, Crystal Stone plays a pivotal role in shaping the strategic direction of customer-facing teams, ensuring that the organization delivers exceptional value to its clients in the clinical research landscape. With a robust background in Good...
As the Senior Director of Customer Engagement at Remarque Systems, Crystal Stone plays a pivotal role in shaping the strategic direction of customer-facing teams, ensuring that the organization delivers exceptional value to its clients in the clinical research landscape. With a robust background in Good Clinical Practice (GCP) and drug development, Crystal leads a diverse team that encompasses Project Management, Data Analytics, Customer Partnership, Training, and Quality Assurance. This multifaceted approach allows Remarque to provide comprehensive support to Sponsors and Contract Research Organizations (CROs) as they navigate the complexities of Clinical Trial Management Systems (CTMS) and Clinical Data Platforms.
Under Crystal's leadership, the team is engaged in key projects aimed at enhancing the functionality and usability of Remarque's platform. These initiatives focus on mitigating study risks and performing thorough data reviews across all data sources, ensuring the highest quality of data integrity and compliance throughout the clinical trial process. Crystal's expertise in clinical monitoring and cross-functional team leadership enables her to foster collaboration among various stakeholders, driving innovation and efficiency in clinical research operations.
Moreover, Crystal is committed to empowering her team through targeted training programs that enhance their skills in biomedical engineering and protocol adherence, particularly in specialized fields such as cardiology and medical devices. By prioritizing customer engagement and satisfaction, Crystal Stone not only strengthens Remarque's position in the industry but also contributes to the advancement of clinical research practices, ultimately improving patient outcomes and accelerating the drug development process.
